SHR-A1904 in Advanced Colorectal Cancer: an Exploratory Study
NCT07700719 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2026-07-14
Summary
To evaluate the safety and efficacy of SHR-A1904 in the advanced colorectal cancer after failure of standard therapy
Conditions
- Colorectal Cancer Metastatic
Interventions
- DRUG
-
SHR-A1904
SHR-A1904
Sponsors & Collaborators
-
Beijing GoBroad Hospital
collaborator OTHER -
Peking University Cancer Hospital & Institute
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-28
- Primary Completion
- 2027-11-28
- Completion
- 2028-04-28
Countries
- China
Study Locations
More Related Trials
-
A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457）
NCT04298320 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer
NCT06373133 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer
NCT07134205 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study
NCT07515820 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
An Explorative Study of HRS-2189 Combined With Adebrelimab and BP102 for Metastatic Colorectal Cancer
NCT07061210 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer
NCT04771715 ·Status: UNKNOWN
-
Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer
NCT06584318 ·Status: RECRUITING ·Phase: NA
-
A Study of ES104 in Patients With Metastatic Colorectal Cancer
NCT05167448 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
NCT04835324 ·Status: UNKNOWN
-
Phase Ib/II Study of QL1706 + Fruquintinib + SCRT vs. Standard Third-Line Therapy in Unresectable Liver-Metastatic pMMR/MSS Colorectal Cancer: Safety, Tolerability, and Efficacy.
NCT07353268 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer
NCT06666166 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer
NCT06363552 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer
NCT03545711 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NCT06751914 ·Status: RECRUITING ·Phase: NA
-
Second-line Surufatinib Combined With Chemotherapy in Advanced CRC
NCT04734249 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies
NCT03274882 ·Status: COMPLETED ·Phase: PHASE2
-
The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening
NCT05304741 ·Status: UNKNOWN
-
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study
NCT05600309 ·Status: COMPLETED ·Phase: PHASE3
-
Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line
NCT05372198 ·Status: UNKNOWN ·Phase: PHASE2
-
Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status
NCT06356714 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer
NCT02688023 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC
NCT06322563 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
NCT07050394 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study of JMT101 in Patients With Metastatic Colorectal Cancer
NCT06089330 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal Cancer
NCT03397199 ·Status: UNKNOWN ·Phase: PHASE2